France Digestives & Intestinal Remedies Market Insight
Published: 31 August 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The France digestives & intestinal remedies market is forecasted to see a rise in the market size at a growth rate of 4.1% due to the growing incidence of digestive diseases, high demand for self-medication remedies, growing aged population, and ongoing demand from consumers for remedies for gastrointestinal complaints.
France Digestives & Intestinal Remedies Market Insights Forecasts to 2035
- The France Digestives & Intestinal Remedies Market Size Was Estimated USD 661.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 4.1% from 2025 to 2035
- The France Digestives & Intestinal Remedies Market Size is Expected to rise around USD 989.4 Million by 2035
Notable Insights for the France Digestives & Intestinal Remedies Market
- The type-based market segmentation shows that the Digestive Medicines segment dominates in the France Digestives & Intestinal Remedies Market, having a revenue share of 56.27% in the year 2024 because of their popular application for treating various digestive disorders.
- The age group based segmentation shows that the Adult & Geriatric segment is one of the important segments in the France Digestives & Intestinal Remedies Market because of increased frequency of digestive disorders in elderly patients.
- Global revenues for Consumer Health from Bayer AG are expected to reach an estimated €5.80 billion by 2025, out of which revenues from the Digestive Health line were estimated to be around €937 million, experiencing a growth rate of 3.7%.
- As expected, the increasing population of older people and digestive disorders will contribute to the expansion of the market, whereas the increased awareness of prolonged PPI usage along with competition from natural products will impact product demand in France.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Digestives & Intestinal Remedies Market
The France digestives & intestinal remedies market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with pharmaceutical manufacturers and distributors, pharmacies, healthcare organizations, gastroenterology specialists, and experts to analyze demand trends, product developments, consumer preferences, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, scientific papers, healthcare data, import-export data, and industry organizations in connection with pharmaceutical and digestive health industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, product demand, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Digestives & Intestinal Remedies Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Digestives & Intestinal Remedies Market
- Bayer AG
- Johnson & Johnson
- GSK PLC
- Procter & Gamble Co
- Sanofi SA
- Boehringer Ingelheim
- Reckitt Benckiser Group PLC
- Abbott Laboratories
- Takeda Pharmaceutical Co Ltd
- Menarini Group
Recent Developments:
- In March 2026, Opella has entered into a strategic collaboration with Verb Biotics in France to co-develop and commercialize the next-generation probiotic strain, thereby enhancing its microbiome-based approach for digestive well-being.
- In November 2025, French pharmaceutical firm Mayoly spent more than €15 million in France in order to increase the production capability of the treatment of irritable bowel syndrome Meteospasmyl by adding two new packing lines at their Dammarie-les-Lys plant.
Market Segmentation:
France Digestives & Intestinal Remedies Market, By Type
- Digestive Medicines
- Remedies Against Gastrointestinal Complaints
- Natural and Synthetic Agents
France Digestives & Intestinal Remedies Market, By Age Group
- Pediatric
- Adult & Geriatric
France Digestives & Intestinal Remedies Market, By Distribution Channel
- Offline
- Online
Expert Views:
The development of digestive & gastrointestinal medicines markets in France will be assisted through the presence of a high incidence of digestive ailments, growing elderly population, and increased preference of self-medication products. Usage of digestive medications, gastrointestinal medicines, natural products, and existing OTC brands will help in expanding the market, whereas the involvement of pharmacies and other existing health care distribution channels will remain significant for the market.
Author: Govind and Krishna By Decisions Advisors and Consulting